Stem cell use in pediatric congenital heart disease trial

Mayo Clinic is announcing the first stem cell clinical trial for pediatric congenital heart disease in the United States.

The trial aims to determine how stem cells from autologous umbilical cord blood can help children with hypoplastic left heart syndrome (HLHS).

 

Video: broadcastmed.com